NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)

Technical Analysis Report for NASDAQ stock AKTX Akari Therapeutics. Dated: 09 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics

Akari Therapeutics Opened at 0.25 and Closed at: 0.25, which is 8% of previous session's close. It moved within a range of 0.23 and 0.26
The session was a Neutral session with an average volume of 130000, which is -28.54% of previous session's volumes.

Support for tomorrow is 0.24 and resistance for tomorrow is 0.27
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.23, 0.22 resistance for tomorrow's hourly charts is 0.26, 0.28

10 Day SMA for Akari Therapeutics (AKTX) is 0.24 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Akari Therapeutics (AKTX) is 0.26 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Akari Therapeutics (AKTX) is 0.29 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 0.53 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Akari Therapeutics is 0.83 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Akari Therapeutics is at 0.26 and 200 DMA is at 0.83, while 50 DMA and 100 DMA are at 0.29 and 0.53 respectively

Akari Therapeutics (AKTX) moving average of 20 SMA is at 0.26 and 20 EMA is at 0.28

Akari Therapeutics (AKTX) moving average of 50 SMA is at 0.29 and 50 EMA is at 0.35

Akari Therapeutics (AKTX) moving average of 100 SMA is at 0.53 and 100 EMA is at 0.48

Akari Therapeutics (AKTX) moving average of 200 SMA is at 0.83 and 200 EMA is at 0.73

Dentsply Sirona has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 20.22% more returns!

Akari Therapeutics has performed better than Xeris Pharmaceuticals in short term. Holding Akari Therapeutics could be a better choice for now!

Spero Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Spero Therapeutics, about 4.73% more returns!

Akari Therapeutics has performed better than Summit Therapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics has performed better than Rocket Pharmaceuticals in short term. Holding Akari Therapeutics could be a better choice for now!

Uniqure N has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Uniqure N, about 23.77% more returns!

Akari Therapeutics has performed better than Quidel Corporation in short term. Holding Akari Therapeutics could be a better choice for now!

Orasure Technologies has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Orasure Technologies, about 15.54% more returns!

Opko Health has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Opko Health, about 2.44% more returns!

Akari Therapeutics has performed better than Oncolytics Biotech in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics has performed better than National Research in short term. Holding Akari Therapeutics could be a better choice for now!

Adial Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Adial Pharmaceuticals, about 1254.19% more returns!

Aquestive Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 22.96% more returns!

Audentes Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Audentes Therapeutics, about 3.45% more returns!

Akari Therapeutics has performed better than Collplant Holdings in short term. Holding Akari Therapeutics could be a better choice for now!

Delcath Systems has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Delcath Systems, about 7.41% more returns!

Akari Therapeutics has performed better than Genprex Inc in short term. Holding Akari Therapeutics could be a better choice for now!

Ironwood Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Ironwood Pharmaceuticals, about 18.75% more returns!

Akari Therapeutics has performed better than Jaguar Health in short term. Holding Akari Therapeutics could be a better choice for now!

Akari Therapeutics Technical analysis of indicators

Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.

Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Akari Therapeutics in short term and BUY signal is strong.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Akari Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.24 and Akari Therapeutics AKTX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.

Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AKTX Experts View which covers a lot of information including buying and selling signals

AKTX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet